Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women

American Journal of Physiology

Volumn 281, Issue 6 PART 1, 2001, Pages

  Wolthers, Troels ^a   Hoffman, David M ^a   Nugent, Ailish G ^a   Duncan, Mark W ^b   Umpleby, Margot ^b   Ho, Ken K Y ^a,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Insulin like growth factor I; Lipid oxidation; Protein turnover

Indexed keywords

EID: 33747312538     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Burman P, Broman JE, Hetta J, Kiklund I, Erfurth EM, Hagg E, and Karlsson FA. Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant GH in a placebo-controlled 21 month trial. J Clin Endocrinol Metab 80: 3585-3590, 1995.
2. Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho KKY, Laron Z, Sizonenko P, Sonksen PH, Tanaka T, and Thorner MO. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. J Clin Endocrinol Metab 83: 382-395, 1998.
3. Chetkowski RJ, Meldrum DR, Steingold KA, Randle D, Lu JK, Eggena P, Hershman JM, Alkjaersig NK, Fletcher AP, and Judd HL. Biological effects of transdermal estradiol. N Engl J Med 314: 1615-1620, 1986.
4. Cook DM, Ludlam WH, and Cook MB. Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults. J Clin Endocrinol Metab 84: 3956-3960, 1999.
5. Drake WM, Coyte D, Camacho-Hubner C, Jivanji NM, Kaltas G, Wood DF, Trainer PJ, Grossman AB, Besser GM, and Monson JP. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. J Clin Endocrinol Metab 83: 3913-3919, 1998.
6. Ferrannini E. The theoretical basis of indirect calorimetry: a review. Metabolism 37: 287-301, 1988.
7. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocrinol Metab 83: 379-381, 1998.
8. Hoffman DM, PR, Duncan M, Nguyen TV, and Ho KKY. How is whole body protein turnover perturbed in adults with growth hormone deficiency? J Clin Endocrinol Metab 83: 4344-4349, 1998.
9. Hoffman DM, O'Sullivan AJ, Baxter RC, and Ho KKY. Diagnosis of growth hormone deficiency in adults. Lancet 343: 1064-1068, 1994.
10. Hoffman DM, O'Sullivan AJ, Freund J, and Ho KKY. Adults with growth hormone deficiency have abnormal body composition but normal energy metabolism. J Clin Endocrinol Metab 80: 72-77, 1995.
11. Horber F and Raymond M. Human growth hormone prevents the protein catabolic effects of prednisone in humans. J Clin Invest 86: 265-272, 1990.
12. Horber FF, Horber-Feyder CM, Krayer S, Schwenk WF, and Haymond MW. Plasma reciprocal pool specific activity predicts that of intracellular free leucine protein synthesis. Am J Physiol Endocrinol Metab 257: E385-E399, 1989.
13. Janssen YJH, Helmerhorst F, Frolich M, and Roelfsema F. A switch from oral (2mg/day) to transdermal (50 g/day) 17β estradiol therapy increases serum insulin-like growth factor levels in recombinant human growth hormone-substituted women with GH deficiency. J Clin Endocrinol Metab 85: 464-467, 2000.
14. Jorgensen JOL, Theusen L, Ingemann-Hansen T, Pedersen SA, Jorgensen J, and Christiansen JS. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1: 1221-1225, 1989.
15. Kelly JJ, Rajkovic IA, O'Sullivan AJ, Sernia C, and Ho KKY. Effects of different oestrogen formulations on insulin-like growth factor-1, growth hormone and growth hormone binding protein in post-menopausal women. Clin Endocrinol (Oxf) 39: 561-567, 1993.
16. Lim L, Spencer SA, McKay P, and Waters MJ. Regulation of growth hormone (GH) bioactivity by a recombinant human GH-binding protein. Endocrinology 127: 1287-1291, 1990.
17. Mannor DA, Winer LM, Shaw MA, and Baumann G. Plasma growth hormone binding proteins: effects on growth hormone binding to receptors and on growth hormone action. J Clin Endocrinol Metab 73: 30-34, 1991.
18. 13C]leucine. Am J Physiol Endocrinol Metab 238: E473-E479, 1980.
19. Nissen SL, Van Huysen C, and Haymond MW. Measurement of branch chain amino acids and branched chain a-ketoacids in plasma by high performance liquid chromatography. J Chromatogr A 232: 170-175, 1982.
20. Ockner RK, Lysenko N, Manning JA, Monroe SE, and Burnett DA. Sex steroid modulation of fatty acid utilization and fatty acid binding protein concentration in rat liver. J Clin Invest 65: 1013-1023, 1980.
21. O'Sullivan AJ, Crampton L, Freund J, and Ho KKY. Route of estrogen replacement confers divergent effects on energy metabolism and body composition in postmenopausal women. J Clin Invest 102: 1035-1040, 1998.
22. O'Sullivan AJ and Ho KKY. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women. J Clin Endocrinol Metab 80: 1783-1788, 1995.
23. O'Sullivan AJ, Hoffman DM, and Ho KKY. Estrogen, lipid oxidation and body fat. N Engl J Med 333: 660-670, 1995.
24. O'Sullivan AJ, Kelly JJ, Hoffman DM, Baxter RC, and Ho KKY. Energy metabolism and substrate utilization in acromegaly. J Clin Endocrinol Metab 80: 486-491, 1995.
25. Powers M, Schenkel L, Darley P, Good W, Balestra J, and Place V. Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17β estradiol: comparison with conventional oral estrogens used in hormone replacement. Am J Obstet Gynecol 152: 1099-1106, 1985.
26. Salomon F, Cuneo RC, Hesp R, and Sonksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 321: 1797-1803, 1989.
27. Schwenk WF, Beaufree B, and Raymond MW. Use of the reciprocal pool specific activities to model leucine metabolism. Am J Physiol Endocrinol Metab 249: E646-E650, 1985.
28. Sjorgen K, Liu JL, Blad K, Skrtic S, Vidai O, Wallenius V, Leroith D, Tornell J, Isaksson O, Jansson JO, and Ohlsson C. Liver-derived insulin-like growth factor I (IGF-I) is the principal souce of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci USA 96: 7088-7092, 1999.
29. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, and Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 325: 1196-1204, 1991.
30. Weinstein I, Soler-Argilaga C, Werner HV, and Heimberg M. Effects of ethynyloestradiol on the metabolism of [1-14C] oleate by perfused livers and hepatocytes from female rats. Biochem J 180: 265-271, 1979.
31. Weissberger AJ, Ho KY, and Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor 1 and GH binding protein in post-menopausal women. J Clin Endocrinol Metab 72: 374-381, 1991.
32. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, and LeRoith D. Normal growth and development in the absence of hepatic insulin-like growth factor 1. Proc Natl Acad Sci USA 96: 7324-7329, 1999.